SCHEMBL14153156

SCHEMBL14153156

C/N=C(\N)c1ccc(-c2cccc(F)c2)cn1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAP4K4 O95819 3/20 0.44
▸ CHEK2 O96017 2/20 0.44
▸ TAAR1 Q96RJ0 3/20 0.44
▸ ESR2 Q92731 1/20 0.44
▸ HPGDS O60760 1/20 0.43
▸ FYN P06241 2/20 0.41
▸ HSD17B1 P14061 2/20 0.40
▸ HSD17B2 P37059 2/20 0.40
▸ PDGFRB P09619 1/20 0.39
▸ PDGFRA P16234 1/20 0.39
▸ NPC1 O15118 1/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ KMO O15229 1/20 0.38
▸ PLK4 O00444 1/20 0.37
▸ CHEK1 O14757 1/20 0.37
▸ AURKA O14965 1/20 0.37
▸ DAPK3 O43293 1/20 0.37
▸ CDK1 P06493 1/20 0.37
▸ PIM1 P11309 1/20 0.37
▸ FGFR1 P11362 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14153034 0.87 MAP4K4 (0.45) MAP4K4CHEK2TAAR1ESR2HPGDS
SCHEMBL14153514 0.78 TAAR1 (0.53) MAP4K4CHEK2TAAR1ESR2HPGDS
SCHEMBL14153548 0.78 GRM5 (0.57) —
SCHEMBL16892862 0.76 ESR2 (0.46) MAP4K4CHEK2TAAR1ESR2FYN
SCHEMBL486067 0.75 KMO (0.59) MAP4K4CHEK2TAAR1ESR2HPGDS
Acetic Acid SCHEMBL27957503 0.72 HIF1A (0.47) MAP4K4CHEK2
SCHEMBL16512756 0.71 ESR2 (0.60) MAP4K4CHEK2TAAR1ESR2HPGDS
SCHEMBL1477226 0.71 MAP4K4 (0.70) MAP4K4CHEK2TAAR1ESR2DYRK1A
SCHEMBL10165304 0.71 TAAR1 (0.50) MAP4K4TAAR1ESR2PDGFRBPDGFRA
SCHEMBL1912349 0.70 GABRA1 (0.51) MAP4K4CHEK2ESR2HPGDSKMO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012162635-A1 METABOTROPIC GLUTAMATE RECEPTORS 5 MODULATORS AND METHODS OF USE THEREOF SUNOVION PHARMACEUTICALS INC. (US) 2012-11-29 — — WO disclosed
Send feedback